REJUVIQ
Mark Identification

REJUVIQ

Serial Number

87766080

Filing Date

Jan 23, 2018

Trademark by

TEVA PHARMACEUTICALS USA INC.

Classification Information

Pharmaceuticals preparations for the prevention and treatment of central nervous system disorders; Pharmaceuticals preparations for the prevention and treatment of circulatory systems disorders; Pharmaceuticals preparations for the prevention and treatment of sensory organs disorders; Pharmaceuticals preparations for the prevention and treatment of urogenital organs disorders; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Contraceptive preparations; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Fertility enhancing preparations; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders

Pharmaceuticals